Feedback
Settings

Settings

Goto Application

1,884 results
Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 189
1.WO/2022/061420FORMULATIONS COMPRISING BOTANICAL EXTRACTS
WO - 31.03.2022
Int.Class A61K 31/365
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
365Lactones
 Appl.No PCT/AU2021/051126 Applicant APEX BIOTECH RESEARCH PTY LTD Inventor XIAO, Zhicheng
The invention relates generally to combinations and compositions comprising botanical extracts useful in the treatment or prevention of viral and bacterial infections. In particular, the invention relates to combinations and compositions comprising two or more compounds selected from andrographolide or a derivative, or pharmaceutically acceptable salt thereof, ursolic acid, or a pharmaceutically acceptable salt thereof, and piceid or a derivative, or pharmaceutically acceptable salt thereof and use of the combinations and compositions in the treatment or prevention of viral and bacterial infections.
2.20250144163THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19
US - 08.05.2025
Int.Class A61K 36/53
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
 Appl.No 18387274 Applicant Peter Joseph Mollick Inventor Peter Joseph Mollick

A therapeutic treatment for the treatment of COVID-19 disease, the treatment to be initiated soon after and preferably within approximately twenty four hours after a patient develops the first signs of symptoms comprising but not limited to individually or in combination thereof fever, headache, sore joints, cough, fatigue, chills. The treatment consists of the oral administration of an extracted component or a combination of extracted components of an herb thyme leaf also know as common thyme (Thymus Vulgaris). The treatment is thought to inhibit the replication and activity of the virus allowing the patient to regain normal health and assist in developing immunity to the virus. The treatment is not known to completely eliminate the virus from the patient therefore resulting in the patient possibly developing the same or different symptoms of the disease a second, or more times requiring additional treatments of the disclosed thyme therapeutic treatment.

3.WO/2021/202823THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19
WO - 07.10.2021
Int.Class A61K 36/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
 Appl.No PCT/US2021/025298 Applicant MOLLICK, Peter J. Inventor MOLLICK, Peter J.
A therapeutic treatment for the treatment of COVID-19 disease, the treatment to be initiated soon after and preferably within approximately twenty four hours after the patient develops the first signs of symptoms comprising but not limited to individually or in combination thereof fever, headache, sore joints, cough, fatigue, chills. The treatment consists of the oral administration of the herb thyme, also know as common thyme (Thymus vulgaris). The treatment is thought to inhibit the replication and activity of the virus allowing the patient to regain normal health and assist in developing immunity to the virus. The treatment is not known to completely eliminate the virus from the patient therefore resulting in the patient possibly developing the same or different symptoms of the disease a second, or more times requiring additional treatments of the disclosed thyme therapeutic treatment.
4.WO/2022/049288ANTIVIRAL AGENTS
WO - 10.03.2022
Int.Class A61K 36/61
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
 Appl.No PCT/EP2021/074502 Applicant G. POHL-BOSKAMP GMBH & CO. KG Inventor UECK, Henning
The present invention relates to a composition comprising eucalyptus oil and sweet orange oil for use in a method for the treatment of a viral infection.
5.WO/2025/046109COMBINATION OF ELDERBERRY EXTRACT AND QUININE FOR THE PROPHYLAXIS AND TREATMENT OF RNA VIRUS INFECTIONS
WO - 06.03.2025
Int.Class A61K 36/35
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
35Caprifoliaceae (Honeysuckle family)
 Appl.No PCT/EP2024/074355 Applicant IPRONA LANA AG/SPA Inventor SETZ, Christian
The present application relates to a combination of elderberry extract and quinine for use in the prevention or treatment of RNA virus infections, in particular coronavirus and influenza virus infections. Pharmaceutic compositions and advantageous formulation techniques are disclosed. Moreover, the present invention also relates to anthocyanin compounds and phenolic compounds which may be obtained from elderberry extract, or other suitable sources, or synthesized de novo, and their respective use(s) in the prevention or treatment of RNA virus infections, in particular coronavirus infections. Moreover, the present invention also relates to elderberry extract, for use as a monotherapy in the prevention or treatment of influenza virus infections. Furthermore, the present invention also relates to quinine, for use as a monotherapy in the prevention or treatment of influenza virus infections. Furthermore, the present invention also relates to combinations of individual anthocyanin compounds or phenolic compounds with quinine, and to the use(s) of such combinations in the prevention or treatment of RNA virus infections, in particular coronavirus and influenza virus infections.
6.20210251945Compounds and pharmaceutical uses thereof
US - 19.08.2021
Int.Class A61K 31/351
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
351not condensed with another ring
 Appl.No 17014774 Applicant SyneuRx International (Taiwan) Corp. Inventor Guochuan Emil Tsai

A method of treating coronavirus infection, comprising administering to a subject in need thereof an effective amount of a composition, wherein the composition comprises one or more compounds of Formula (I):

embedded image
or a pharmaceutically acceptable salt thereof.

7.WO/2022/038472PHYTOTHERAPEUTIC COMPOSITION
WO - 24.02.2022
Int.Class A61K 36/81
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
 Appl.No PCT/IB2021/057464 Applicant MANENT TOMAS, Lluís Inventor MANENT TOMAS, Lluís
A phytotherapeutic composition, for the treatment of Covid-19 and other viral infections, comprising nicotine-containing parts of a species of the genus Nicotiana, optionally in combination with one or more of the species Allium sativum, Zingiber officinale and Curcuma longa, in the form of a liquid nasal, liquid oral, or liquid ocular formulation.
8.WO/2021/202988COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE
WO - 07.10.2021
Int.Class A61K 36/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
 Appl.No PCT/US2021/025564 Applicant TURTLE BEAR HOLDINGS, LLC Inventor STAMETS, Paul E.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.
9.WO/2021/202982COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE
WO - 07.10.2021
Int.Class A23L 31/00
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
31Edible extracts or preparations of fungi; Preparation or treatment thereof
 Appl.No PCT/US2021/025553 Applicant TURTLE BEAR HOLDINGS, LLC Inventor STAMETS, Paul, E.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mushroom mycelium and/or fruit body mixture, optionally combined with one or more buffering agents, ethanol, and water.
10.20210308200Compositions and methods for modulating inflammatory response
US - 07.10.2021
Int.Class A61K 36/07
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
 Appl.No 17221437 Applicant TURTLE BEAR HOLDINGS, LLC Inventor Paul E. Stamets

Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.

# -